Cargando…

Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.

Detalles Bibliográficos
Autores principales: Sekido, Katsuhisa, Imaue, Shuichi, Tomihara, Kei, Tachinami, Hidetake, Yamagishi, Kentaro, Okazawa, Seisuke, Ikeda, Atsushi, Fujiwara, Kumiko, Noguchi, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405368/
https://www.ncbi.nlm.nih.gov/pubmed/34484745
http://dx.doi.org/10.1002/ccr3.4545
_version_ 1783746319500705792
author Sekido, Katsuhisa
Imaue, Shuichi
Tomihara, Kei
Tachinami, Hidetake
Yamagishi, Kentaro
Okazawa, Seisuke
Ikeda, Atsushi
Fujiwara, Kumiko
Noguchi, Makoto
author_facet Sekido, Katsuhisa
Imaue, Shuichi
Tomihara, Kei
Tachinami, Hidetake
Yamagishi, Kentaro
Okazawa, Seisuke
Ikeda, Atsushi
Fujiwara, Kumiko
Noguchi, Makoto
author_sort Sekido, Katsuhisa
collection PubMed
description Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.
format Online
Article
Text
id pubmed-8405368
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84053682021-09-03 Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report Sekido, Katsuhisa Imaue, Shuichi Tomihara, Kei Tachinami, Hidetake Yamagishi, Kentaro Okazawa, Seisuke Ikeda, Atsushi Fujiwara, Kumiko Noguchi, Makoto Clin Case Rep Case Report Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective. John Wiley and Sons Inc. 2021-08-30 /pmc/articles/PMC8405368/ /pubmed/34484745 http://dx.doi.org/10.1002/ccr3.4545 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Sekido, Katsuhisa
Imaue, Shuichi
Tomihara, Kei
Tachinami, Hidetake
Yamagishi, Kentaro
Okazawa, Seisuke
Ikeda, Atsushi
Fujiwara, Kumiko
Noguchi, Makoto
Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
title Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
title_full Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
title_fullStr Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
title_full_unstemmed Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
title_short Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
title_sort durable complete response to immunotherapy with anti‐pd‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405368/
https://www.ncbi.nlm.nih.gov/pubmed/34484745
http://dx.doi.org/10.1002/ccr3.4545
work_keys_str_mv AT sekidokatsuhisa durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT imaueshuichi durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT tomiharakei durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT tachinamihidetake durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT yamagishikentaro durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT okazawaseisuke durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT ikedaatsushi durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT fujiwarakumiko durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport
AT noguchimakoto durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport